FSRH Clinical Guideline: Progestogen-only Injectable (December 2014, Amended October 2020)
This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables (depot medroxyprogesterone acetate (DMPA), Depo-Provera) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.
You are welcome to download our freely available Guideline documents by clicking on the document title above.
This document is up-to-date